177Lu-R11228
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-R11228, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer [Phase 1]